{"id":"https://openalex.org/W4387810296","doi":"https://doi.org/10.1016/j.annonc.2023.09.2754","title":"1806P Efficacy of niraparib and abiraterone acetate plus prednisone (NIRA+AAP) in homologous recombination repair gene-altered (HRR+) metastatic castration-resistant prostate cancer (mCRPC) by tissue and/or plasma assays in the MAGNITUDE trial","display_name":"1806P Efficacy of niraparib and abiraterone acetate plus prednisone (NIRA+AAP) in homologous recombination repair gene-altered (HRR+) metastatic castration-resistant prostate cancer (mCRPC) by tissue and/or plasma assays in the MAGNITUDE trial","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387810296","doi":"https://doi.org/10.1016/j.annonc.2023.09.2754"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2023.09.2754","doi":"https://doi.org/10.1016/j.annonc.2023.09.2754","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.09.2754","pdf_url":"http://www.annalsofoncology.org/article/S0923753423035913/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.annalsofoncology.org/article/S0923753423035913/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000156180","display_name":"Gerhardt Attard","orcid":"https://orcid.org/0000-0002-4811-7983","observed_orcids":["https://orcid.org/0000-0002-4811-7983"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Attard","raw_affiliation_strings":["Research Department of Oncology, University College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department of Oncology, University College London, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064026461","display_name":"Shahneen Kaur Sandhu","orcid":"https://orcid.org/0000-0002-8660-4475","observed_orcids":["https://orcid.org/0000-0002-8660-4475"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"S.K. Sandhu","raw_affiliation_strings":["Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002358672","display_name":"Dana E. Rathkopf","orcid":"https://orcid.org/0000-0002-4503-7582","observed_orcids":["https://orcid.org/0000-0002-4503-7582"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Rathkopf","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077861800","display_name":"Elena Castro","orcid":"https://orcid.org/0000-0002-3691-6454","observed_orcids":["https://orcid.org/0000-0002-3691-6454"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E. Castro","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108672655","display_name":"Marniza Bte Saad","orcid":"https://orcid.org/0000-0003-3768-4808","observed_orcids":["https://orcid.org/0000-0003-3768-4808"]},"institutions":[{"id":"https://openalex.org/I1296788130","display_name":"University Malaya Medical Centre","ror":"https://ror.org/00vkrxq08","country_code":"MY","type":"healthcare","lineage":["https://openalex.org/I1296788130"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"M. Saad","raw_affiliation_strings":["Department of Clinical Oncology, UMMC - University Malaya Medical Centre, Kuala Lumpur, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, UMMC - University Malaya Medical Centre, Kuala Lumpur, Malaysia","institution_ids":["https://openalex.org/I1296788130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089854184","display_name":"Mitchell Reed Smith","orcid":"https://orcid.org/0000-0003-1428-8765","observed_orcids":["https://orcid.org/0000-0003-1428-8765"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.R. Smith","raw_affiliation_strings":["Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.J.J. Small","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer Center, University of California San Francisco Medical Center, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, University of California San Francisco Medical Center, San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072116005","display_name":"David Olmos","orcid":"https://orcid.org/0000-0002-7003-4826","observed_orcids":["https://orcid.org/0000-0002-7003-4826"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"D. Olmos","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108985773","display_name":"A.J.P.D.S. Gomes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.J.P.D.S. Gomes","raw_affiliation_strings":["Department of Medical Oncology, Liga Norte Riograndense Contra o C\u00e2ncer, Natal, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Liga Norte Riograndense Contra o C\u00e2ncer, Natal, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068223483","display_name":"Guilhem Roubaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Roubaud","raw_affiliation_strings":["Department of Medical Oncology, Institute Bergoni\u00e9, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institute Bergoni\u00e9, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012327350","display_name":"Bogdan A. \u017burawski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137953","display_name":"Centrum Onkologii","ror":"https://ror.org/03vzf8p77","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210137953"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"B. Zurawski","raw_affiliation_strings":["Department of Clinical Oncology, Franciszek \u0141ukaszczyk Oncology Centre, Bydgoszcz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Franciszek \u0141ukaszczyk Oncology Centre, Bydgoszcz, Poland","institution_ids":["https://openalex.org/I4210137953"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078910130","display_name":"Eleni Efstathiou","orcid":"https://orcid.org/0000-0002-3868-1396","observed_orcids":["https://orcid.org/0000-0002-3868-1396"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Efstathiou","raw_affiliation_strings":["GU Medical Oncology Department, The M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GU Medical Oncology Department, The M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Wu","raw_affiliation_strings":["Clinical Oncology Department, Janssen Research & Development, LLC, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology Department, Janssen Research & Development, LLC, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074009410","display_name":"B. Diorio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Diorio","raw_affiliation_strings":["Clinical Oncology Department, Janssen Research & Development, LLC, Titusville, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology Department, Janssen Research & Development, LLC, Titusville, NJ, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002472469","display_name":"Karen A. Urtishak","orcid":"https://orcid.org/0000-0002-5718-4424","observed_orcids":["https://orcid.org/0000-0002-5718-4424"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Urtishak","raw_affiliation_strings":["Department of Oncology Translational Research, Janssen Research & Development, LLC, Spring House, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Translational Research, Janssen Research & Development, LLC, Spring House, PA, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002409424","display_name":"Umesh Pratap Singh","orcid":"https://orcid.org/0000-0003-1830-6262","observed_orcids":["https://orcid.org/0000-0003-1830-6262"]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U. Singh","raw_affiliation_strings":["Department of Oncology Diagnostics, Janssen Research & Development, LLC, Raritan, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Diagnostics, Janssen Research & Development, LLC, Raritan, NJ, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065380119","display_name":"Yan Xu","orcid":"https://orcid.org/0000-0002-2832-2664","observed_orcids":["https://orcid.org/0000-0002-2832-2664"]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Xu","raw_affiliation_strings":["Department of Oncology Diagnostics, Janssen Research & Development, LLC, Raritan, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Diagnostics, Janssen Research & Development, LLC, Raritan, NJ, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020669411","display_name":"Angela Mennicke Lopez- Gitlitz","orcid":"https://orcid.org/0000-0003-3323-7605","observed_orcids":["https://orcid.org/0000-0003-3323-7605"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Lopez-Gitlitz","raw_affiliation_strings":["Clinical Oncology Department, Janssen Research & Development, LLC, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology Department, Janssen Research & Development, LLC, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029778834","display_name":"A. del Corral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. del Corral","raw_affiliation_strings":["Clinical Oncology Department, Janssen Research & Development, LLC, Bridgewater, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology Department, Janssen Research & Development, LLC, Bridgewater, NJ, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109782836","display_name":"K.N. Chi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"K.N.N. Chi","raw_affiliation_strings":["Department of Medical Oncology, BC Cancer - Vancouver, Vancouver, BC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, BC Cancer - Vancouver, Vancouver, BC, Canada","institution_ids":["https://openalex.org/I1289530486"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":15,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4060,"currency":"USD","value_usd":4060},"apc_paid":null,"fwci":0.177,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.52275683,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"34","issue":null,"first_page":"S976","last_page":"S977"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.861299991607666,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.861299991607666,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.13279999792575836,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/niraparib","display_name":"niraparib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9750000238418579},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9819999933242798},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9359999895095825},{"id":"https://openalex.org/keywords/homologous-recombination-repair","display_name":"homologous recombination repair","score":0.9240000247955322},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6869999766349792},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9268760681152344},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.7127562761306763},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6253788471221924},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.602039635181427},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.5942033529281616},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5000877380371094},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49065080285072327},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39556118845939636},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3810209631919861},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.14802202582359314},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.08549091219902039},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.07215419411659241}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2023.09.2754","doi":"https://doi.org/10.1016/j.annonc.2023.09.2754","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.09.2754","pdf_url":"http://www.annalsofoncology.org/article/S0923753423035913/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2023.09.2754","doi":"https://doi.org/10.1016/j.annonc.2023.09.2754","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.09.2754","pdf_url":"http://www.annalsofoncology.org/article/S0923753423035913/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387810296.pdf","grobid_xml":"https://content.openalex.org/works/W4387810296.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W4387810315"],"related_works":["https://openalex.org/W4415941989","https://openalex.org/W4212780237","https://openalex.org/W4310753925","https://openalex.org/W4324136916","https://openalex.org/W4281768533","https://openalex.org/W4382794886","https://openalex.org/W4387809547","https://openalex.org/W4360608257","https://openalex.org/W4324137164","https://openalex.org/W7155193853"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2023-10-21T00:00:00"}